The National Institute for Biotechnology in the Negev; Ltd.
发明人:
申请号：
EP12814486.2
公开号：
EP2734541B1
申请日:
2012.07.18
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
Provided are engineered soluble hIL-17RA receptors with high affinity to hIL-17 that inhibit downstream IL17A induced signaling events in cells. Also provided are methods of inhibiting hIL-17A induced secretion of CXCL1 and/or IL-6 in cells, as well as methods of treating inflammation and/or inflammatory disorders in a subject.
